Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zero Candida TechnologiesTSXV:ZCT 15 12-1 Month Momentum % is -40.00% as of Sep. 08, 2026. GuruFocus rates TSXV:ZCT with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 824 Medical Devices & Instruments companies, Zero Candida Technologies ranks worse than 77.67% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-09-08), Zero Candida Technologies's 12-1 Month Momentum % is -40.00%.
The industry rank for Zero Candida Technologies's 12-1 Month Momentum % or its related term are showing as below:
TSXV:ZCT's 12-1 Month Momentum % is ranked worse than 77.67% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: -16.95
vs TSXV:ZCT: -40.00
Zero Candida Technologies (TSXV:ZCT) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Zero Candida Technologies 12-1 Month Momentum % Related Terms
TSXV:ZCT vs ABT, SYK, MDT: 12-1 Month Momentum % Comparison
For the Medical Devices subindustry, Zero Candida Technologies's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zero Candida Technologies 12-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zero Candida Technologies's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Zero Candida Technologies's 12-1 Month Momentum % falls into.
Zero Candida Technologies (TSXV:ZCT) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -40.00% mean?
Zero Candida Technologies (TSXV:ZCT) has a 12-1 Month Momentum % of -40.00% as of Sep. 08, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Zero Candida Technologies and its competitors. According to the industry distribution chart, Zero Candida Technologies ranks #640 out of 824 companies in the Medical Devices & Instruments industry, placing it in the top 77.7%.
Is Zero Candida Technologies' 12-1 Month Momentum % too high?
Zero Candida Technologies' current 12-1 Month Momentum % is -40.00%. Based on the distribution chart, Zero Candida Technologies ranks #640 out of 824 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Zero Candida Technologies has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Zero Candida Technologies' 12-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zero Candida Technologies ranks #640 out of 824 companies for 12-1 Month Momentum %. This places Zero Candida Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Devices & Instruments company?
A good 12-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Zero Candida Technologies and its competitors. Zero Candida Technologies's current 12-1 Month Momentum % is -40.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zero Candida Technologies stock overvalued right now?
Zero Candida Technologies (TSXV:ZCT) has a current 12-1 Month Momentum % of -40.00%. The current 12-1 Month Momentum % is -40.00%. Zero Candida Technologies' overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Zero Candida Technologies (TSXV:ZCT), the current 12-1 Month Momentum % is -40.00% as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zero Candida Technologies Inc is engaged in providing female healthcare solutions. The company technology uses a controlled Blue Light to destroy the fungus at record speed and without side effects. It focused on developing and commercializing several patents and patent applications concerning an AI smart tampon-like device, designed to treat Candidiasis and transfer medical information via Wi-Fi to the doctor.
15GF Score
Get the complete analysis for TSXV:ZCT
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:ZCT has been successfully added to your 
